Insider Sale: TER President/CEO disposes 554 shares under 10b5-1
Rhea-AI Filing Summary
Reporting person: Gregory Stephen Smith, who serves as President and CEO and a director of Teradyne, Inc. (TER), reported an insider sale on Form 4. The transaction occurred on 08/12/2025 and was reported on a Form 4 signed by an attorney-in-fact on 08/14/2025. The filing shows 554 shares of Teradyne common stock were sold at a price of $106 per share pursuant to a pre-established Rule 10b5-1 sales plan adopted on February 4, 2025. After the reported sale, the filing shows the reporting person beneficially owns 96,992.995 shares directly.
Positive
- Sale executed under a documented Rule 10b5-1 plan adopted on February 4, 2025, indicating pre-planned disposition
- Full disclosure provided on Form 4, including transaction date, price, and post-transaction beneficial ownership of 96,992.995 shares
Negative
- Reporting person disposed of 554 shares of Teradyne common stock on 08/12/2025
- Transaction recorded at $106 per share, reducing the reporting person’s direct holdings
Insights
TL;DR: A routine 10b5-1 sale by Teradyne's CEO of a small number of shares; filing provides clear disclosure of amount and remaining ownership.
The Form 4 documents a single non-derivative sale by Gregory S. Smith executed under a 10b5-1 plan, which typically indicates the trade was pre-planned and not opportunistic. The sale of 554 shares at $106 is explicitly disclosed along with the post-transaction direct beneficial ownership of 96,992.995 shares. For most investors, this filing is a transparency item rather than evidence of a material change in ownership or control.
TL;DR: The transaction follows a documented 10b5-1 plan and was properly reported on Form 4, reflecting compliance with insider-trading protocols.
The disclosure states the shares were sold pursuant to a sales plan adopted on February 4, 2025, satisfying Rule 10b5-1 affirmative defense conditions as noted in the explanation. The Form 4 is signed by an attorney-in-fact, indicating procedural adherence. The filing contains no additional governance events or changes in officer/director status.